Gelion plc

Gelion plc, founded in 2015 and headquartered in Eveleigh, Australia, specializes in the comprehensive process of battery systems. This includes their investigation, conceptualization, engineering, manufacturing, and distribution, serving clients both within the United Kingdom and internationally. The company's prominent offering is its Endure range of zinc-bromide batteries. These energy storage solutions are deployed across a broad spectrum of applications, such as powering industrial light towers, providing storage for renewable energy installations like solar and wind farms, supporting desalination efforts, operating mining pumps, electrifying various modes of transport including passenger vehicles, heavy-duty trucks, electric buses, and trains, and fulfilling requirements for irrigation and other agricultural tasks. Additionally, their products are utilized by commercial and industrial entities, as well as by operators of electricity grids.

Gelion plc trades as GELN.L on LSE. The company is classified in Industrials / Electrical Equipment & Parts and reports in GBP.

The current profile places the business in Electrical Equipment & Parts. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows £912,000 of revenue and -£5.98M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Gelion plc can be compared against peers such as Defence Holdings PLC, Billington Holdings Plc, eEnergy Group Plc, Flowtech Fluidpower plc, Logistics Development Group plc, Lords Group Trading PLC.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £34.12M, beta of 0.47, and return on equity of -60.0%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

GELN.L currently shows total debt of £27,000 and beta of 0.47. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.gelion.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.